Peer Review History
Original SubmissionJuly 6, 2020 |
---|
PONE-D-20-20869 Hemodynamic effects of high frequency oscillatory ventilation with volume guarantee in a piglet model of respiratory distress syndrome PLOS ONE Dear Dr. Bhogal, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. As noted by the reviewers, there are several issues that need to be addressed. Both question why a recruitment maneuver was not performed. In addition, reviewer #1notes that the main factor influencing cardiac output is the transmural pressure, not MAP. Please discuss this comment. There are other areas that I identified that also need to be addressed. Why is the BP of the SHAM animals so low at 240 min? Since cardiac output was unchanged, the level of anesthesia could explain the decrease in cerebral NIRS and carotid blood flow. This needs to be discussed. How was anesthesia adjusted? Was it the same for all animals? In Figure 3B, the y-axis is labeled change in cerebral NIRS but the text refers to absolute values. Please graph the absolute values. Please submit your revised manuscript by Oct 23 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Richard Bruce Mink Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: No Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: In the hypothesis the authors established that during HFOV combined to VG, amplitude pressure is titrated to maintain tidal volume and this can affect cardiac output. The authors speculate that the only finding of a decrease in the Carotid artery flow index and NIRS in the HFOV + VG group is due to speculate fluctuating of amplitude during HFOV+VG may resulting in fluctuating positive intrathoracic pressure, which would contribute to changing preload for the right ventricle that ultimately impacts the LV preload. LV afterload may similarly fluctuate in this context resulting overall in a negative impact on cardiac output. But the authors didn’t find any differences between the intervention groups in the stroke volume, changes of tau, dP/dt max, ejection fraction, stroke work, dP/dt min, end-diastolic volume and pressure obtained from Millar® catheter .Also it has been demonstrated in an experimental model that delta P generated by the ventilator is not transmitted into the airways, also as the authors demonstrated the is no different effect over the time on CO when compared Vg vs no VG. Animal model, it is missed a maneuver of lung recruitment after BAL. Method, the measurement of delta pressure is missed, this is the main variable during HFOV with the VG modality, if VT is similar between both modalities, then delta P should be also similar and no differences at all will be found, unless the ventilator used clearly work different during the VG modality. It is not well described the ventilator used for the study, and how the VG works, if this is the Fabian device, not many studies have been done with this device and as it is well known, the device used during HFOV clearly can affect the results. Most of the studies published to date used the VN500 from Dragger, so results can’t be clearly compared. Results, in additional information from the animals, the two animals with the lower NIRS values in the Vg group are the two who had lower CO at the stable condition. CA data from the VG group are missed in two animals at 240 min and very low in three at 120 min, so comparison is quite difficult to be done against the non VG group. Minute volume is represented during the HFOV but this value is of no interest during this modality of ventilation as the ventilation is more accurately represented by the DCO2. pH values in the VG group showed a very acidotic situation in one animal from the beginning of the study. Final comments, this is an interest study exploring the potential different effect of the VG modality when used in combination with HFOV instead to not using it. The main problem is related to the design as if the classical variable during standard HFOV is related to the Vt and during VG it is related to delta P, if the ventilator, tubbing and lung condition are similar and there is no interaction between the animal and the ventilator, then both modalities are exactly the same with minimal fluctuation in delta P to maintain the set Vt in the VG added to HFOV, and minimal fluctuation in Vt when delta P is set in the no VG modality. So the expected differences between both would be mostly related to changes in the lung and patient condition during ventilation. If the patient’s lung is stable, then both modalities will work equal at similar Vt. Reviewer #2: The presented study has examined the hemodynamic effects of HFOV with and without VG in the newborn piglets with RDS. In general, the study is well established and written . -Open lung strategy is the key element of lung protective strategies. Generally, in cases with diffuse atelectasis, as in the RDS, lung recruitment maneuver at the initiation of HFOV or HFOV-VG stabilise alveoli and improves oxygenation. Besides a few exceptions, current practice at the initiation of HFOV or HFOV-VG involves lung recruitment maneuvers. Why the authors did not optimise lung volumes using lung recruitment maneuver ? ... If open lung strategy had been used , piglets posssibly would need lower MAP and and may need lower amplitude / TVhf levels to improve oxygen delivery and to achieve normocarbic levels. On the other side, recruitment could have temporarily increased transpulmonary pressure and could have effected the results. The effect of open lung strategy may be dependent of the selected HFOV strategy (With or without V). It would be good to discuss the possible effects of the lung recruitment maneuvers to the results. Besides lung recruitment, results can not directly be extrapolated to newborn babies with RDS without surfactant administration and use of inotropic drug. - MAP is the strongest effector of intra thorasic pressure, however TVhf do not directly effects it. Therefore, systemic circulation is possibly efffected by MAP levels rather than VThf levels. Increased hypotension and lower perfusion findings with HFOV-VG mode compared to HFOV mode ( using similar MAP levels ) sounds interesting and needs to be emphasized. Is there a clear relationship between amplitude and intrathorasic pressure since intrathorasic is mainly effected by MAP It is valuable in terms of contribution to the literature, but some issues need to be explained. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 1 |
Hemodynamic effects of high frequency oscillatory ventilation with volume guarantee in a piglet model of respiratory distress syndrome PONE-D-20-20869R1 Dear Dr. Bhogal, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Richard Bruce Mink Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
Formally Accepted |
PONE-D-20-20869R1 Hemodynamic effects of high frequency oscillatory ventilation with volume guarantee in a piglet model of respiratory distress syndrome Dear Dr. Bhogal: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Richard Bruce Mink Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .